NCT04307134 2025-12-31Besponsa Post Marketing Surveillance StudyPfizerCompleted108 enrolled 39 charts
NCT05597085 2025-02-04A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last TreatmentPfizerCompleted32 enrolled 31 charts